Last updated 2026-09-18
- Raised grant, Sep 2026
Total raised
—
Last: Grant 2026-09
Stage
Pre-Seed
Founded
2026
Headcount
—
HQ
New York, United States
Sector
Health Tech & Life Sciences
About
Ariadne Bio is a clinical-stage neuropsychiatry company focused on developing AB-300, a non-hallucinogenic serotonin 2A receptor agonist, to treat apathy in Parkinson's disease and other brain aging conditions. The company was spun out of Palomar Labs and is advancing AB-300 into a Phase 1b clinical trial with funding from The Michael J. Fox Foundation for Parkinson's Research.
Funding history · 1 round · — total
1 event/round · — Total Funding
Sep 2026
Offices
New York, United States · HQ / main office
Q&A
- What is Ariadne Bio's primary focus?
- Ariadne Bio is a clinical-stage neuropsychiatry company focused on developing AB-300, a non-hallucinogenic serotonin 2A receptor agonist, to treat apathy in Parkinson's disease and other brain aging conditions.
- When was Ariadne Bio founded?
- Ariadne Bio was founded in September 2026.
- What is the current stage of Ariadne Bio?
- Ariadne Bio is currently in the Pre-Seed stage.
- Which organization provided a grant to Ariadne Bio?
- In September 2026, Ariadne Bio received a grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).
- What is the name of Ariadne Bio's lead therapeutic candidate?
- Ariadne Bio's lead therapeutic candidate is AB-300.
- What is the planned clinical trial for AB-300?
- Ariadne Bio is advancing AB-300 into a Phase 1b clinical trial.
- Who is the Founder and CEO of Ariadne Bio?
- Shlomi Raz is the Founder and Chief Executive Officer of Ariadne Bio.
- Where is Ariadne Bio headquartered?
- Ariadne Bio is headquartered in New York, United States.
Team · 4
Shlomi Raz
Founder · Founder and Chief Executive Officer
Shlomi Raz
Founder and Chief Executive Officer
Kostia Adamsky
Chief Operating Officer
Daniel E. Jeffries
Chief Development Officer
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Tags
biotechnologyneuropsychiatryparkinson's-diseasedrug-developmentclinical-stage
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ariadnebio.com |
|---|---|
| linkedin.com/company/ariadne-bio/ |
Identifiers & details
| Legal name | Ariadne Bio, Inc. |
|---|---|
| Founded | 2026-9 |